Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease

Nutrition

Volumn 24, Issue 3, 2008, Pages 239-244

  Cheng, Chien Hsiung ^a,b   Lin, Ping Ting ^c   Liaw, Yung Po ^b   Ho, Chien Chang ^b   Tsai, Tsung Po ^d   Chou, Ming Chih ^b,d   Huang, Yi Chia ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG CHOU INSTITUTE OF TECHNOLOGY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Case control; Coronary artery disease; High sensitivity C reactive protein; Inflammation; Pyridoxal 5 phosphate

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; LIPID; PYRIDOXAL 5 PHOSPHATE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; PRIORITY JOURNAL; RISK;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PYRIDOXAL PHOSPHATE; RISK FACTORS; VITAMIN B 6; VITAMIN B 6 DEFICIENCY; VITAMIN B COMPLEX;

EID: 38749125143     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.12.003     Document Type: Article

References (43)

1. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
2. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of fasting plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
3. Rydlewicz A., Simpson J.A., Taylor R.J., Bond C.M., and Golden M.H.N. The effect of folic acid supplementation on fasting plasma homocysteine in an elderly population. Q J Med 95 (2002) 27-35
4. Ford E.S., Smith S.J., Stroup D.F., Steinberg K.K., Mueller P.W., and Thacker S.B. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31 (2002) 59-70
5. Bautista L.E., Arenas I.A., Penuela A., and Martinez L.X. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 55 (2002) 882-887
6. Serfontein W.J., Ubbink J.B., de Villiers L.S., Rapley C.H., and Becker P.J. Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease. Aterosclerosis 55 (1985) 357-361
7. Robinson K., Mayer E.L., Miller D.P., Green R., van Lente F., Gupta A., et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 92 (1995) 2825-2830
8. 6, and lipid in cardiovascular disease. Nutrition 18 (2002) 595-598
9. Lee B.J., Huang M.C., Chung L.J., Cheng C.H., Su K.H., and Huang Y.C. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Eur J Clin Nutr 58 (2004) 481-487
10. Brattström L., Israelsson B., Norrving B., Bergqvist D., Thorne J., Hultberg B., and Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 81 (1990) 51-60
11. Miller J.W., Ribaya-Mercado J.D., Russell R.M., Shepard D.C., Morrow F.D., Cochary E.F., et al. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr 55 (1992) 1154-1160
12. Ubbink J.B., Vermaak W.J.H., van der Merwe A., Becker P.J., Delport R., and Potgieter H.C. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 124 (1994) 1927-1933
13. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
14. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
15. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
16. Di Napoli M., Papa F., and Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32 (2001) 917-924
17. Kullo I.J., Gau G.T., and Tajik A.J. Novel risk factors for atherosclerosis. Mayo Clin Proc 75 (2000) 369-380
18. 6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 103 (2001) 2788-2791
19. 6. Arthritis Res Ther 7 (2005) R1254-R1262
20. Galloway P., McMillan D.C., and Sattar N. Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem 37 (2000) 289-297
21. Talwar D., Quasim T., McMillan D.C., Kinsella J., Williamson C., and O'Reilly D.S. Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response. Clin Chem 49 (2003) 515-518
22. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422 (1987) 43-52
23. Bates C.J., Pentieva K.D., Matthews N., and Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Clin Chem Acta 280 (1999) 101-111
24. Dominici R., Luraschi P., and Franzini C. Measurement of C-reactive protein: two high sensitivity methods compared. J Clin Lab Anal 18 (2004) 280-284
25. Leklem J.E. Vitamin B6: a status report. J Nutr 120 (1990) 1503-1507
26. Food and Nutrition Board-Institute of Medicine. Dietary reference intakes. Thiamin, riboflavin, niacin, vitamin B-6, folate, vitamin B-12, pantothenic acid, biotin, and choline (1998), National Academy Press, Washington, DC
27. Lui A., Lumeng L., Aronoff G.R., and Li T.K. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med 106 (1985) 491-497
28. Friso S., Firelli D., Martinelli N., Olivieri O., Lotto V., Bozzini C., et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 79 (2004) 992-998
29. Kelly P.J., Kistler J.P., Shih V.E., Mandell R., Atassi N., Barron M., et al. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke 35 (2004) 12-15
30. Folsom A.R., Desvarieux M., Nieto F.J., Boland L.L., Ballantyne C.M., and Chambless L.E. B vitamin status and inflammatory markers. Atherosclerosis 169 (2003) 169-174
31. Huang Y.C., Chang H.H., Huang S.C., Cheng C.H., Lee B.J., Cheng S.Y., and Su K.H. Plasma pyridoxal 5′-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill. Nutrition 21 (2005) 779-785
32. Gray A., McMillan D.C., Wilson C., Williamson C., O'Reilly D.St.J., and Talwar D. The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phospahte following elective knee arthroplasty. Clin Nutr 23 (2004) 1080-1083
33. Quasim T., McMillan D.C., Talwar D., Vasilaki A., O'Reilly D.St.J., and Kinsella J. The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients. Clin Nur 24 (2005) 956-960
34. Dierkes J., Weikert C., Klipstein-Grobusch K., Westphal S., Luley C., Möhlig M., Spranger J., and Boeing H. Plasma pyridoxal 5′-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort. Am J Clin Nutr 86 (2007) 214-220
35. Harripersad R., and Burger F.J. The effect of a subnormal dose of vitamin B6 on plasma lipid in the rat. Int J Vitam Nutr Res 67 (1997) 95-101
36. Pregnolato P., Maranesi M., Marchetti M., Barzanti V., Bergami R., and Tolomelli B. Interaction among dietary vitamin B6, proteins and lipids: effects on liver lipids in rats. Int J Vitam Nutr Res 64 (1994) 263-269
37. Lin P.T., Cheng C.H., Liaw Y.P., Lee B.J., Lee T.W., and Huang Y.C. Low pyridoxal 5′-phosphate is associated with increased risk of coronary artery disease. Nutrition 22 (2006) 1146-1151
38. Binder C.J., Chang M.-K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., and Witztum J.L. Innate and acquired immunity in atherogenesis. Nat Med 23 (2002) 535-541
39. Greaves D.R., and Channon K.M. Inflammation and immune responses in atherosclerosis. Trends Immunol 8 (2002) 1257-1262
40. Talbott M.C., Miller L.T., and Kerkvliet N.I. Pyridoxine supplementation: effect on lymphocyte responses in elderly persons. Am J Clin Nutr 46 (1987) 659-664
41. Folkers K., Morita M., and McRee Jr. J. The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem Biophys Res Commun 193 (1993) 88-92
42. Meydani S.N., Ribaya-Mercado J.D., Russell R.M., Sahyoun N., Morrow F.D., and Gershoff S.N. Vitamin B-6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elderly adults. Am J Clin Nutr 53 (1991) 1275-1280
43. 6 supplementation improves immune responses in critically ill patients. Eur J Clin Nutr 60 (2006) 1207-1213